uniQure N.V. (NASDAQ: QURE)
$9.03
-0.0850 ( -0.93% ) 576.0K
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Market Data
Open
$9.03
Previous close
$9.11
Volume
576.0K
Market cap
$437.43M
Day range
$8.92 - $9.41
52 week range
$3.73 - $11.35
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Dec 19, 2023 |
8-k | 8K-related | 13 | Nov 17, 2023 |
10-q | Quarterly Reports | 64 | Nov 07, 2023 |
8-k | 8K-related | 14 | Nov 07, 2023 |
def | Proxies and info statements | 21 | Oct 06, 2023 |
8-k | 8K-related | 14 | Oct 05, 2023 |
3 | Insider transactions | 2 | Oct 02, 2023 |
4 | Insider transactions | 1 | Sep 20, 2023 |
8-k | 8K-related | 16 | Aug 01, 2023 |
10-q | Quarterly Reports | 62 | Aug 01, 2023 |